Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Simon

Showing results (51-60 of 234) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patientsBoris Freidlin, Richard Simon
Cancer Informatics|June 5, 2010
Development and validation of predictive indices for a continuous outcome using gene expression profilesYingdong Zhao, Richard Simon
Nature Reviews. Drug Discovery|May 1, 2013
Implementing personalized cancer genomics in clinical trialsRichard Simon, Sameek Roychowdhury
Journal of Biopharmaceutical Statistics|July 16, 2019
Finding the intended use population for a new treatmentRichard Simon, Noah Simon
Genome Medicine|January 8, 2011
Gene expression deconvolution in clinical samplesYingdong Zhao, Richard Simon
Statistics in Medicine|February 22, 2011
An evaluation of resampling methods for assessment of survival risk prediction in high-dimensional settingsJyothi Subramanian, Richard Simon
Biostatistics (Oxford, England)|December 25, 2004
Sample size determination in microarray experiments for class comparison and prognostic classificationKevin Dobbin, Richard Simon
Contemporary Clinical Trials|July 2, 2013
Overfitting in prediction models - is it a problem only in high dimensions?Jyothi Subramanian, Richard Simon
Journal of the National Cancer Institute|October 8, 2013
Run-in phase III trial design with pharmacodynamics predictive biomarkersFangxin Hong, Richard Simon
Personalized Medicine|May 16, 2018
Clinical trials for precision oncology using next-generation sequencingRichard Simon, Eric Polley
Pageof 24

Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patientsBoris Freidlin, Richard Simon
Cancer Informatics|June 5, 2010
Development and validation of predictive indices for a continuous outcome using gene expression profilesYingdong Zhao, Richard Simon
Nature Reviews. Drug Discovery|May 1, 2013
Implementing personalized cancer genomics in clinical trialsRichard Simon, Sameek Roychowdhury
Journal of Biopharmaceutical Statistics|July 16, 2019
Finding the intended use population for a new treatmentRichard Simon, Noah Simon
Genome Medicine|January 8, 2011
Gene expression deconvolution in clinical samplesYingdong Zhao, Richard Simon
Statistics in Medicine|February 22, 2011
An evaluation of resampling methods for assessment of survival risk prediction in high-dimensional settingsJyothi Subramanian, Richard Simon
Biostatistics (Oxford, England)|December 25, 2004
Sample size determination in microarray experiments for class comparison and prognostic classificationKevin Dobbin, Richard Simon
Contemporary Clinical Trials|July 2, 2013
Overfitting in prediction models - is it a problem only in high dimensions?Jyothi Subramanian, Richard Simon
Journal of the National Cancer Institute|October 8, 2013
Run-in phase III trial design with pharmacodynamics predictive biomarkersFangxin Hong, Richard Simon
Personalized Medicine|May 16, 2018
Clinical trials for precision oncology using next-generation sequencingRichard Simon, Eric Polley
Pageof 24